[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Quick Uptakes
August 26, 1998

No ACE Up Their Sleeve

Author Affiliations

Not Available

Not Available

JAMA. 1998;280(8):687. doi:10.1001/jama.280.8.687-JQU80005-5-1

Even though US physicians are heeding the call to offer angiotensin-converting enzyme (ACE) inhibitors to more patients with myocardial infarction (MI), the drugs remain underprescribed.

A new study has examined data on diagnoses and prescriptions at discharge for 200000 patients with MI who were treated at 1400 US hospitals between 1994 and 1996. The report, by researchers at the University of California, San Francisco, School of Medicine, showed that ACE inhibitor prescriptions rose to 38.7% in 1996 from 25% in 1994. But the researchers said only half of patients who could have benefited most from the drug—those with congestive heart failure—received it. The study is in this month's Journal of the American College of Cardiology.

First Page Preview View Large
First page PDF preview
First page PDF preview